NCT00114634View on ClinicalTrials.gov

Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Smith-Lemli-Opitz Syndrome
Interventions
DIETARY_SUPPLEMENT

Egg yolk preparation with cholesterol

Egg yolk preparation with cholesterol

DIETARY_SUPPLEMENT

Egg substitute, without cholesterol

Placebo control. Egg substitute, without cholesterol

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00114634 - Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome | Biotech Hunter | Biotech Hunter